| pubmed-article:18559872 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18559872 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18559872 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:18559872 | lifeskim:mentions | umls-concept:C0024301 | lld:lifeskim |
| pubmed-article:18559872 | lifeskim:mentions | umls-concept:C0393022 | lld:lifeskim |
| pubmed-article:18559872 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
| pubmed-article:18559872 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:18559872 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:18559872 | pubmed:issue | 21 | lld:pubmed |
| pubmed-article:18559872 | pubmed:dateCreated | 2008-7-21 | lld:pubmed |
| pubmed-article:18559872 | pubmed:abstractText | The treatment of patients with follicular lymphoma has changed with the introduction of high-dose therapy (HDT) with autologous stem-cell transplant then with rituximab. The effect of these two strategies on the outcome of relapsing patients with follicular lymphoma has never been compared. | lld:pubmed |
| pubmed-article:18559872 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18559872 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18559872 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18559872 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18559872 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18559872 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18559872 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18559872 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:18559872 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:18559872 | pubmed:author | pubmed-author:MounierNicola... | lld:pubmed |
| pubmed-article:18559872 | pubmed:author | pubmed-author:BricePaulineP | lld:pubmed |
| pubmed-article:18559872 | pubmed:author | pubmed-author:CoiffierBertr... | lld:pubmed |
| pubmed-article:18559872 | pubmed:author | pubmed-author:TillyHervéH | lld:pubmed |
| pubmed-article:18559872 | pubmed:author | pubmed-author:FeugierPierre... | lld:pubmed |
| pubmed-article:18559872 | pubmed:author | pubmed-author:BrousseNicole... | lld:pubmed |
| pubmed-article:18559872 | pubmed:author | pubmed-author:HaiounCorinne... | lld:pubmed |
| pubmed-article:18559872 | pubmed:author | pubmed-author:Solal-Céligny... | lld:pubmed |
| pubmed-article:18559872 | pubmed:author | pubmed-author:DelarueRichar... | lld:pubmed |
| pubmed-article:18559872 | pubmed:author | pubmed-author:SebbanCatheri... | lld:pubmed |
| pubmed-article:18559872 | pubmed:author | pubmed-author:SouleauBertra... | lld:pubmed |
| pubmed-article:18559872 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18559872 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:18559872 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:18559872 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18559872 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18559872 | pubmed:pagination | 3614-20 | lld:pubmed |
| pubmed-article:18559872 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:meshHeading | pubmed-meshheading:18559872... | lld:pubmed |
| pubmed-article:18559872 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18559872 | pubmed:articleTitle | Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study. | lld:pubmed |
| pubmed-article:18559872 | pubmed:affiliation | Centre Léon Bérard, Lyon, France. | lld:pubmed |
| pubmed-article:18559872 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18559872 | lld:pubmed |
